hD

Income Statement Summary

Dusa Pharmaceuticals (DUSA) annual income statement covering fiscal 2009 through 2011, as reported to the SEC.

  • Gross profit was $38.37M in fiscal 2011, up 27.9% from $30M.
  • Income from operations was $7.76M, up 184.5% from $2.73M.
  • Net income was $7.32M, up 170.8% from $2.7M.
  • Diluted net income per share was $0.28, up 154.5% from $0.11.

An income statement shows what a company sold and what it cost to run the business, ending with the profit left over.

Figures in USD thousands, except per share data
Dec'11Dec'10Dec'09
Product revenues

45,296

36,423

28,338

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Product revenues

45,296

36,423

28,338

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Cost of product revenues

6,921

6,419

6,007

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Cost of product revenues

6,921

6,419

6,007

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

GROSS MARGIN

38,374

30,003

22,331

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

GROSS MARGIN

38,374

30,003

22,331

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Research and development

5,275

4,929

4,313

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Research and development

5,275

4,929

4,313

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Marketing and sales

15,382

13,240

12,897

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Marketing and sales

15,382

13,240

12,897

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

General and administrative

9,956

9,105

7,956

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

General and administrative

9,956

9,105

7,956

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

TOTAL OPERATING COSTS

30,614

27,276

25,167

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

TOTAL OPERATING COSTS

30,614

27,276

25,167

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

INCOME FROM OPERATIONS

7,759

2,727

-2,835

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

INCOME FROM OPERATIONS

7,759

2,727

-2,835

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Other income

46

226

290

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Other income

46

226

290

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

(Loss) gain on change in fair value of warrants

-1,013

-390

-376

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

(Loss) gain on change in fair value of warrants

-1,013

-390

-376

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

INCOME (LOSS) FROM CONTINUING OPERATIONS, BEFORE INCOME TAX BENEFIT

6,793

2,563

-2,921

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

INCOME (LOSS) FROM CONTINUING OPERATIONS, BEFORE INCOME TAX BENEFIT

6,793

2,563

-2,921

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Income tax benefit

-

-

-162

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Income tax benefit

-

-

-162

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

(LOSS) INCOME FROM CONTINUING OPERATIONS

6,793

2,563

-2,758

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

(LOSS) INCOME FROM CONTINUING OPERATIONS

6,793

2,563

-2,758

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

(LOSS) INCOME FROM DISCONTINUED OPERATIONS

526

139

250

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

(LOSS) INCOME FROM DISCONTINUED OPERATIONS

526

139

250

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

NET (LOSS) INCOME

7,319

2,702

-2,508

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

NET (LOSS) INCOME

7,319

2,702

-2,508

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

CONTINUING OPERATIONS

0.28

0.11

-0.11

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

CONTINUING OPERATIONS

0.28

0.11

-0.11

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

DISCONTINUED OPERATIONS

0.02

0.01

0.01

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

DISCONTINUED OPERATIONS

0.02

0.01

0.01

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

BASIC NET (LOSS) INCOME PER SHARE

0.30

0.11

-0.10

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

BASIC NET (LOSS) INCOME PER SHARE

0.30

0.11

-0.10

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

CONTINUING OPERATIONS

0.26

0.10

-0.11

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

CONTINUING OPERATIONS

0.26

0.10

-0.11

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

DISCONTINUED OPERATIONS

0.02

0.01

0.01

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

DISCONTINUED OPERATIONS

0.02

0.01

0.01

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

DILUTED NET (LOSS) INCOME PER SHARE

0.28

0.11

-0.10

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

DILUTED NET (LOSS) INCOME PER SHARE

0.28

0.11

-0.10

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, BASIC

24,531

24,188

24,102

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, BASIC

24,531

24,188

24,102

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, DILUTED

26,352

24,765

24,134

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, DILUTED

26,352

24,765

24,134

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx